Geminin Overexpression Promotes Imatinib Sensitive Breast Cancer: A Novel Treatment Approach for Aggressive Breast Cancers, Including a Subset of Triple Negative

Zannel Blanchard(University of Mississippi Medical Center), Wael M. ElShamy(University of Mississippi Medical Center)

PLoS ONE

April 30, 2014

10.1371/journal.pone.0095663

Cited by 26

Related Papers

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers

|Breast Cancer Research|2015|49

Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells

|Breast Cancer Research|2011|32

Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers

|Oncotarget|2016|22